Employee stock option governance tightened; new disclosure, valuation and listing requirements and trust consolidation rules. Amendments expand definitions, require a Compensation Committee and prescribed Disclosure Document, mandate disclosure of valuation method and, if intrinsic value is used, disclosure of the difference from fair value and its impact on profits and EPS. Schedule III prescribes fair value measurement and assumptions; Schedule IV prescribes pre grant disclosures. Repricing needs shareholder approval; listing rules require filings and in principle approvals, special IPO ratification and prospectus disclosures for pre IPO ESOS/ESPS shares; trust administration must be consolidated under AS21.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Employee stock option governance tightened; new disclosure, valuation and listing requirements and trust consolidation rules.
Amendments expand definitions, require a Compensation Committee and prescribed Disclosure Document, mandate disclosure of valuation method and, if intrinsic value is used, disclosure of the difference from fair value and its impact on profits and EPS. Schedule III prescribes fair value measurement and assumptions; Schedule IV prescribes pre grant disclosures. Repricing needs shareholder approval; listing rules require filings and in principle approvals, special IPO ratification and prospectus disclosures for pre IPO ESOS/ESPS shares; trust administration must be consolidated under AS21.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.